Cognitive-behavioural therapy for late-life anxiety disorders: A systematic review and meta-analysis

Acta Psychiatrica Scandinavica

Volumn 117, Issue 6, 2008, Pages 403-411

  Hendriks, G J ^a,b,c   Oude Voshaar, R C ^c   Keijsers, G P J ^b   Hoogduin, C A L ^b   Van Balkom, A J L M ^d  

^a Forum GGz Nijmegen ^*  (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aged; Anxiety disorders; Cognitive therapy

Indexed keywords

ANXIETY DISORDER; BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DEPRESSION; GENERALIZED ANXIETY DISORDER; HUMAN; META ANALYSIS; PANIC; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SOCIAL PHOBIA; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANXIETY DISORDERS; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; PSYCHOTHERAPY, GROUP; TREATMENT OUTCOME;

EID: 43549095699     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2008.01190.x     Document Type: Review

References (55)

1. Flint AJ. Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 1994 151 : 640 649.
2. Beekman AT, Bremmer MA, Deeg DJ et al. Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psychiatry 1998 13 : 717 726.
3. Lenze EJ, Mulsant BH, Mohlman J et al. Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder. Am J Geriatr Psychiatry 2005 13 : 77 80.
4. Flint AJ. Generalised anxiety disorder in elderly patients: epidemiology, diagnosis and treatment options. Drugs Aging 2005 22 : 101 114.
5. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005 62 : 593 602.
6. Beekman AT, de Beurs E, van Balkom AJ, Deeg DJ, van Dyck R, van Tilburg W. Anxiety and depression in later life: co-occurence and communality of risk factors. Am J Psychiatry 2000 157 : 89 95.
7. De Beurs E, Beekman AT, van Balkom AJ, Deeg DJ, van Dyck R, van Tilburg W. Consequences of anxiety in older persons: its effect on disability, well-being and use of health services. Psychol Med 1999 29 : 583 593.
8. Schuurmans J, Comijs HC, Beekman AT et al. The outcome of anxiety disorders in older people at 6-year follow-up: results from the Longitudinal Aging Study Amsterdam. Acta Psychiatr Scand 2005 111 : 420 428.
9. Wetherell JL, Maser JD, van Balkom A. Anxiety disorders in the elderly: outdated beliefs and a research agenda. Acta Psychiatr Scand 2005 111 : 401 402.
10. APA Steering Committee on Practice Guidelines (ed.). American Psychiatric Association practice guidelines for the treatment of psychiatric disorders compendium. Washington, DC : American Psychiatric Publishing, 2002.
11. Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord 2005 88 : 27 45.
12. Mitte K. Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy. Psychol Bull 2005 131 : 785 795.
13. Furukawa TA, Watanabe N, Churchill R. Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry 2006 188 : 305 312.
14. Norton PJ, Price EC. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. J Nerv Ment Dis 2007 195 : 521 531.
15. Nordhus IH, Pallesen S. Psychological treatment of late-life anxiety: an empirical review. J Consult Clin Psychol 2003 71 : 643 651.
16. Pinquart M, Duberstein PR. Treatment of anxiety disorders in older adults: a meta-analytic comparison of behavioral and pharmacological interventions. Am J Geriatr Psychiatry 2007 15 : 639 651.
17. Ayers CR, Sorrell JT, Thorp SR, Wetherell JL. Evidence-based psychological treatments for late-life anxiety. Psychol Aging 2007 22 : 8 17.
18. Wetherell JL, Kaplan RM, Kallenberg G, Dresselhaus TR, Sieber WJ, Lang AJ. Mental health treatment preferences of older and younger primary care patients. Int J Psychiatry Med 2004 34 : 219 233.
19. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005 62 : 617 627.
20. van Tulder MW, Assendelft WJ, Koes BW, Bouter LM. Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for Spinal Disorders. Spine 1997 20 : 2323 2330.
21. Chalmers TC, Smith H Jr., Blackburn B et al. A method for assessing the quality of a randomized control trial. Control Clin Trials 1981 2 : 31 49.
22. Oude Voshaar RC, Couvee JE, van Balkom AJ, Mulder PG, Zitman FG. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry 2006 189 : 213 220.
23. van Boeijen CA, van Balkom AJ, van Oppen P, Blankenstein N, Cherpanath A, van Dyck R. Efficacy of self-help manuals for anxiety disorders in primary care: a systematic review. Fam Pract 2005 22 : 192 196.
24. Starcevic V, Berle D, Milicevic D, Hannan A, Lamplugh C, Eslick GD. Pathological worry, anxiety disorders and the impact of co-occurrence with depressive and other anxiety disorders. J Anxiety Disord 2007 10 : 1016 1027.
25. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988 56 : 893 897.
26. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959 32 : 50 55.
27. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990 28 : 487 495.
28. van Rijsoort S. The Penn State Worry Questionnaire and the Worry Domains Questionnaire: structure, reliability and validity. Clin Psychol Psychother 1999 6 : 297 307.
29. Beck AT. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988 8 : 77 100.
30. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977 1 : 385 401.
31. Barrowclough C, King P, Colville J, Russell E, Burns A, Tarrier N. A randomized trial of the effectiveness of cognitive-behavioral therapy and supportive counseling for anxiety symptoms in older adults. J Consult Clin Psychol 2001 69 : 756 762.
32. Mohlman J, Gorenstein EE, Kleber M, de Jesus M, Gorman JM, Papp LA. Standard and enhanced cognitive-behavior therapy for late-life generalized anxiety disorder: two pilot investigations. Am J Geriatr Psychiatry 2003 11 : 24 32.
33. Schuurmans J, Comijs H, Emmelkamp PM et al. A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults. Am J Geriatr Psychiatry 2006 14 : 255 263.
34. Stanley MA, Beck JG, De Witt Glassco J. Treatment of generalized anxiety in older adults: a preliminary comparison of cognitive-behavioral and supportive approaches. Behav Ther 1996 27 : 565 581.
35. Stanley MA, Beck JG, Novy DM et al. Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol 2003 71 : 309 319.
36. Stanley MA, Hopko DR, Diefenbach GJ, Bourland SL, Rodriguez H, Wagener P. Cognitive-behavior therapy for late-life generalized anxiety disorder in primary care: preliminary findings. Am J Geriatr Psychiatry 2003 11 : 92 96.
37. Wetherell JL, Gatz M, Craske MG. Treatment of generalized anxiety disorder in older adults. J Consult Clin Psychol 2003 71 : 31 40.
38. Givens JL, Datto CJ, Ruckdeschel K et al. Older patients' aversion to antidepressants. A qualitative study. J Gen Intern Med 2006 21 : 146 151.
39. Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med 2006 119 : 719 727.
40. Weinrieb RM, Auriacombe M, Lynch KG, Lewis JD. Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf 2005 4 : 337 344.
41. Katz IR, Reynolds CF, III., Alexopoulos GS, Hackett D. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials. J Am Geriatr Soc 2002 50 : 18 25.
42. Lenze EJ, Mulsant BH, Shear MK et al. Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry 2005 162 : 146 150.
43. Ensrud KE, Blackwell T, Mangione CM et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 2003 8 : 949 957.
44. French DD, Campbell R, Spehar A, Cunningham F, Bulat T, Luther SL. Drugs and falls in community-dwelling older people: a national veterans study. Clin Ther 2006 28 : 619 630.
45. Kurzthaler I, Wambacher M, Golser K et al. Alcohol and benzodiazepines in falls: an epidemiological view. Drug Alcohol Depend 2005 2 : 225 230.
46. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998 9112 : 1303 1307.
47. Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002 22 : 285 293.
48. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001 158 : 892 898.
49. Rainsford C. Counseling older adults. Rev Clin Gerontol 2002 12 : 159 164.
50. Hyer L, Kramer D, Sohnle S. CBT with older people: alterations and the value of the therapeutic alliance. Psychother Theory Res Pract Train 2004 41 : 276 291.
51. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000 19 : 2529 2536.
52. Bockting CL, Spinhoven P, Koeter MW, Wouters LF, Visser I, Schene AH. Differential predictors of response to preventive cognitive therapy in recurrent depression: a 2-year prospective study. Psychother Psychosom 2006 75 : 229 236.
53. Marks I. Behaviour therapy for obsessive-compulsive disorder: a decade of progress. Can J Psychiatry 1997 42 : 1021 1027.
54. Mitte K. Review: psychotherapy plus antidepressant therapy increases response rate in people with panic disorder more than either treatment alone. Evid Based Ment Health 2006 9 : 98.
55. Nadiga DN, Hensley PL, Uhlenhuth EH. Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder. Depress Anxiety 2003 17 : 58 64.